Medical News Summary: Alimta approved for use against certain cancers in the European Union

About: Alimta approved for use against certain cancers in the European Union
Date: 16 October 2004
Source: Onlypunjab
Medical News Summary (summary of medical news story as reported by Onlypunjab): A company has been authorized by the European Commission to begin marketing Alimta. Alimta is the first approved chemotherapy treatment for patients with malignant pleural mesothelioma in the European Union. It has been shown to be effective and the use of folic acid and vitamin B12 alongside it reduces the side effects dramatically. Research is being conducted for use of Alimta against other cancers as well. Common side effects of Alimta when used with a common chemotherapy agent are: blood and lymphatic system disorders, gastrointestinal disorders, fatigue, sensory disorders, renal and urinary disorders, rash and hair loss.
URL: http://www.onlypunjab.com/real/fullstory-newsID-6762.html
Related Disease Topics: Malignant pleural mesothelioma, Blood and lymphatic system disorders, Gastrointestinal disorders, Fatigue, Sensory disorders, Renal and urinary disorders, Rash and hair loss

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

Cancer
Lung cancer
Medication
medication and cancer
medication and lung cancer
Medication and malignant pleural mesothelioma
Medication and blood system disorders
Medication and lymphatic system disorders
Medication and gastrointestinal disorders
medication and fatigue
Medication and sensory disorders
Medication and renal disorders
medication and urinary disorders
medication and rash
medication and hair loss

Medical Tools & Articles:

Next articles:

Medical Articles: